BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12100914)

  • 1. A prospective, multicenter, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults.
    Jimenez-Cruz F; Jasovich A; Cajigas J; Jiang Q; Imbeault D; Woods GL; Gesser RM;
    Urology; 2002 Jul; 60(1):16-22. PubMed ID: 12100914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Tomera KM; Burdmann EA; Reyna OG; Jiang Q; Wimmer WM; Woods GL; Gesser RM;
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2895-900. PubMed ID: 12183244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
    Park DW; Peck KR; Chung MH; Lee JS; Park YS; Kim HY; Lee MS; Kim JY; Yeom JS; Kim MJ
    J Korean Med Sci; 2012 May; 27(5):476-83. PubMed ID: 22563210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
    Legua P; Lema J; Moll J; Jiang Q; Woods G; Friedland I
    Clin Ther; 2002 Mar; 24(3):434-44. PubMed ID: 11952026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia.
    Vetter N; Cambronero-Hernandez E; Rohlf J; Simon S; Carides A; Oliveria T; Isaacs R;
    Clin Ther; 2002 Nov; 24(11):1770-85. PubMed ID: 12501873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
    Ortiz-Ruiz G; Caballero-Lopez J; Friedland IR; Woods GL; Carides A;
    Clin Infect Dis; 2002 Apr; 34(8):1076-83. PubMed ID: 11914996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    Gesser RM; McCarroll K; Teppler H; Woods GL
    J Antimicrob Chemother; 2003 May; 51(5):1253-60. PubMed ID: 12697633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
    Ortiz-Ruiz G; Vetter N; Isaacs R; Carides A; Woods GL; Friedland I
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii59-66. PubMed ID: 15150184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem therapy for community-acquired pneumonia in the elderly.
    Woods GL; Isaacs RD; McCarroll KA; Friedland IR
    J Am Geriatr Soc; 2003 Nov; 51(11):1526-32. PubMed ID: 14687380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Roy S; Higareda I; Angel-Muller E; Ismail M; Hague C; Adeyi B; Woods GL; Teppler H;
    Infect Dis Obstet Gynecol; 2003; 11(1):27-37. PubMed ID: 12839630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    Bai N; Sun C; Wang J; Cai Y; Liang B; Zhang L; Liu Y; Wang R
    Chin Med J (Engl); 2014; 127(6):1118-25. PubMed ID: 24622445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
    Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
    Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: a multicentre, randomized, double-blind, active-controlled study.
    Leng XS; Zhao YJ; Qiu HZ; Cao YK; Zhu WH; Shen JF; Paschke A; Dai WM; Caldwell N; Wang J
    J Antimicrob Chemother; 2014 Dec; 69(12):3379-86. PubMed ID: 25151205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections.
    Lin HA; Yang YS; Wang JX; Lin HC; Lin DY; Chiu CH; Yeh KM; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2016 Apr; 49(2):237-42. PubMed ID: 25661278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
    N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem: a review of its use in the management of bacterial infections.
    Curran M; Simpson D; Perry C
    Drugs; 2003; 63(17):1855-78. PubMed ID: 12921489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.